Here's a summary of influential Wall Street research ratings that could impact market movements. Below are today's key analyst actions compiled for investors.

**Top 5 Price Target Increases**

UBS: Raised Five Below (FIVE) target from $184 to $204, maintaining "Buy" rating ahead of earnings. The bank noted the stock now shows "clearer trajectory" amid concerns about next year's growth stability.

Oppenheimer: Lifted Deere (DE) target from $512 to $531, keeping "Outperform" rating. The firm highlighted Deere's "price/cost tailwinds" despite $1.2B tariff headwinds, with accelerating tech adoption strengthening its next-cycle positioning. Truist also raised Deere's target from $609 to $612 post-earnings.

Barclays: Increased Abercrombie & Fitch (ANF) target from $84 to $94 after Q3 results, maintaining "Equal Weight." Hollister's 15% same-store sales growth drove revenue in line and profits above expectations.

UBS: Boosted Dillard's (DDS) target from $184 to $460 post-Q3, but kept "Sell" rating citing "very limited" EPS growth potential amid single-digit sales growth and flat margins.

Mizuho: Raised Arcutis Biotherapeutics (ARQT) target from $32 to $37, maintaining "Outperform" as Zoryve prescriptions trend above expectations.

**Notable Price Target Cuts**

Rosenblatt: Trimmed Netflix (NFLX) target from $153 to $152 after model updates including its 1:10 stock split, keeping "Buy" rating.

Barclays: Lowered Dick's Sporting Goods (DKS) target from $246 to $242 post-Q3 results, maintaining "Overweight."

Citi: Cut Flutter Entertainment (FLUT) target from $340 to $320, citing UK tax risks as a "material overhang" for four months.

BofA: Reduced Bilibili (BILI) target from $32 to $31 after meetings, adjusting 2025-2027 EPS estimates for higher interest income but softer ad revenue.

Goldman Sachs: Slashed Nutanix (NTNX) target from $95 to $75, attributing Q1's "lumpy results" to deal timing rather than demand issues.